14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today BLUE ranks #16583 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

bluebird bio Stock Forecast NASDAQ:BLUE

$9.95 (-6.40%)

Volume: 1M

Closed: Dec 03, 2021

Hollow Logo Score: -5.831

bluebird bio Stock Forecast

$9.95 (-6.40%)

Volume: 1M

Closed: Dec 03, 2021

Score Hollow Logo -5.831
Which way will BLUE go? Request
Key Stats
P/E Ratio -0.81
Beta 0.49
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 25 and the stock is currently not being overbought or oversold

bluebird bio stock price fell more than -6.40% Friday closing at $9.95
(Updated on Dec 03, 2021)

Sell candidate since 2021-11-05 Loss -24.28%

The bluebird bio stock price fell by -6.40% on the last day (Friday, 3rd Dec 2021) from $10.63 to $9.95. During the day the stock fluctuated 7.79% from a day low at $9.88 to a day high of $10.65. The price has fallen in 7 of the last 10 days and is down by -8.8% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -296 thousand shares and in total, 1 million shares were bought and sold for approximately $11.99 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.20 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -27.80% during the next 3 months and, with a 90% probability hold a price between $5.92 and $16.18 at the end of this 3-month period.

Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The bluebird bio stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.33 and $15.84. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, November 04, 2021, and so far it has fallen -60.50%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.77 between high and low, or 7.79%. For the last week, the stock has had a daily average volatility of 7.03%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is bluebird bio stock A Buy?

bluebird bio holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.831

Predicted Opening Price for bluebird bio of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$10.16 $9.95 (Undervalued)
Strong Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 12, 2021 "Berenberg Bank" gave "$11.00" rating for BLUE. The price target was changed from $11.15 to 4.5%.

Volatility and Risk
Daily Average Volatility: 7.03 %
Overall Risk: Very High High Medium Low Very Low
7.03 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $10.70
Price: $9.95
No Support Found

BLUE Insider Trading Show all Trades



Last 100 transactions
Buy: 708 540 | Sell: 1 986 874 (Shares)
Date Action Amount Person Type
Nov 11, 2021 Sell 5 000 Sellers William R. Stock Option (right to buy)
Nov 11, 2021 Sell 3 000 Sellers William R. Stock Option (right to buy)
Nov 11, 2021 Sell 8 000 Sellers William R. Stock Option (right to buy)
Nov 11, 2021 Buy 0 Sellers William R. Common Stock
Nov 11, 2021 Sell 25 000 Gregory Philip D Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 708 540 | Sell: 1 986 874 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 10.93 9.85 %
10.64 6.89 %
10.45 5.07 %
Current price: 9.95
Support 9.87 -0.85 %
9.68 -2.67 %
9.39 -5.63 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 11.31 13.67 %
10.76 8.14 %
10.70 7.54 %
Current price 9.95
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell di... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE